Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 01/22/2026 | Q4 | $22.4B | -- | -- | $1.87 | -- |
| 10/24/2025 | Q3 | $22.2B | $22.4B | $1.95 | $1.90 | $0.05 |
| 07/29/2025 | Q2 | $20.8B | $20.9B | $1.48 | $1.42 | $0.06 |
| 04/24/2025 | Q1 | $20.2B | $19.8B | $1.54 | $1.53 | $0.01 |
| 01/22/2025 | Q4 | $21.6B | $21.9B | $1.88 | $1.86 | $0.02 |
| 10/18/2024 | Q3 | $22B | $21.7B | $1.61 | $1.90 | -$0.29 |
| 07/30/2024 | Q2 | $20.7B | $20.5B | $1.27 | $1.37 | -$0.10 |
| 04/19/2024 | Q1 | $20.4B | $20.2B | $1.52 | $1.41 | $0.10 |
| 01/23/2024 | Q4 | $21.5B | $21.4B | $1.41 | $1.70 | -$0.29 |
| 10/18/2023 | Q3 | $21.6B | $21.9B | $1.83 | $1.72 | $0.11 |
| 07/28/2023 | Q2 | -- | $20.6B | $1.37 | -- | -- |
| 04/21/2023 | Q1 | -- | $20.1B | $1.37 | -- | -- |
| 01/19/2023 | Q4 | -- | $20.8B | $1.59 | -- | -- |
| 10/19/2022 | Q3 | -- | $20.6B | $1.57 | -- | -- |
| 07/29/2022 | Q2 | -- | $19.5B | $1.21 | -- | -- |
| 04/20/2022 | Q1 | -- | $19.4B | $1.33 | -- | -- |
| 01/19/2022 | Q4 | -- | $21B | $1.66 | -- | -- |
| 10/19/2021 | Q3 | -- | $20.3B | $1.61 | -- | -- |
| 07/30/2021 | Q2 | -- | $18.9B | $1.13 | -- | -- |
| 04/20/2021 | Q1 | -- | $18.1B | $1.26 | -- | -- |
| 01/20/2021 | Q4 | -- | $19.7B | $1.47 | -- | -- |
| 10/20/2020 | Q3 | -- | $19.3B | $1.63 | -- | -- |
| 07/30/2020 | Q2 | -- | $17.7B | $1.07 | -- | -- |
| 04/21/2020 | Q1 | -- | $17.2B | $1.12 | -- | -- |
| 01/23/2020 | Q4 | -- | $18.2B | $1.41 | -- | -- |
| 10/22/2019 | Q3 | -- | $17.8B | $1.36 | -- | -- |
| 07/30/2019 | Q2 | -- | $17.1B | -$2.12 | -- | -- |
| 04/23/2019 | Q1 | -- | $16.5B | $1.04 | -- | -- |
| 01/23/2019 | Q4 | -- | $17.4B | $1.22 | -- | -- |
| 10/19/2018 | Q3 | -- | $16.7B | $1.22 | -- | -- |
| 07/31/2018 | Q2 | -- | $16.5B | $0.72 | -- | -- |
| 04/20/2018 | Q1 | -- | $16.3B | $0.95 | -- | -- |
| 01/23/2018 | Q4 | -- | $17.4B | $0.93 | -- | -- |
| 10/20/2017 | Q3 | -- | $16.7B | $1.06 | -- | -- |
| 07/27/2017 | Q2 | -- | $16.1B | $0.82 | -- | -- |
| 04/26/2017 | Q1 | -- | $15.6B | $0.93 | -- | -- |
| 01/20/2017 | Q4 | -- | $16.9B | $0.93 | -- | -- |
| 10/25/2016 | Q3 | -- | $16.5B | $0.96 | -- | -- |
| 08/02/2016 | Q2 | -- | $16.1B | $0.69 | -- | -- |
| 04/26/2016 | Q1 | -- | $15.8B | $0.82 | -- | -- |
| 01/26/2016 | Q4 | -- | $16.9B | $1.12 | -- | -- |
Procter & Gamble Co. reported $22.4B worth of top line sales in its most recent quarter.
Procter & Gamble Co. announced earnings per share of $1.95 which represents a beat of analyst forecast a $1.90 per share.
Procter & Gamble Co. reported $11.6B that represents $4.76 per share over the last quarter.
Procter & Gamble Co.'s earnings are forecast to grow from $6.51 per share to $6.77 per share next year representing an increase of 7.57%.
Procter & Gamble Co.'s next earnings date is January 22, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.